Market Overview:
The global tuberculosis testing market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of tuberculosis, growing awareness about tuberculosis testing, and technological advancements in tuberculosis testing. The global tuberculosis testing market is segmented by type into smear microscopy, nucleic acid testing, radiography, culture based tests, drug susceptibility testing, and others. The nucleic acidtesting segment is expected to grow at the highest CAGR during the forecast period owingto its high accuracy and sensitivity. The global tuberculosistesting market is also segmented by application into hospitals, laboratories,,and others. This can be attributed tobethe increasing number of hospital admissions for TB diagnosis and rising demand for rapid TB diagnosis tests.
Product Definition:
A tuberculin skin test is a medical test used to determine if a person has been infected with tuberculosis (TB). The test detects the presence of infection-fighting cells called lymphocytes that are produced in response to the TB bacteria.
Smear Microscopy:
Smear microscopy is a technique used to view the bacteria or their toxins that cause diseases. It uses a thin layer of tissue or skin as a microscope slide and requires little-to-no special equipment other than an optical microscope. The major advantage of this technique is that it does not require specialized laboratory facilities, skilled professionals, and high budget like other advanced techniques such as DNA probes for molecular diagnostics.
Nucleic Acid Testing:
Nucleic acid testing (NAT) is a diagnostic test used for the detection of nucleic acid from patient’s samples. It helps in detecting Mycobacterium tuberculosis (MTB), which is the causative agent ofTB. The test also helps in differentiating between active and latent TB infection (LTBI).
Application Insights:
The market is segmented into hospitals, laboratories and others. Hospitals held the largest share in 2017 owing to the presence of a large number of tuberculosis patients that require diagnosis at an early stage for effective treatment. Moreover, increasing government initiatives to control tuberculosis is further expected to drive the hospital segment over the forecast period.
Treatment facilities are also anticipated to witness lucrative growth due largely on factors such as rising incidence rates of multi-drug resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). According to WHO, around 10 million people were diagnosed with MDR-TB worldwide in 2016 while approximately 1.3 million people were diagnosed with XDR-TB that same year globally.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to increasing number of new cases, rising awareness about TB testing, presence of high unmet clinical needs as well as availability of effective treatment & management strategies for drug-resistant forms. Moreover, growing healthcare infrastructure coupled with supportive government initiatives are some other factors contributing toward growth in this region.
In addition to this, favorable reimbursement policies for smear microscopy and culture based tests are also anticipated to boost revenue generation in Asia Pacific region over the forecast period. In addition, increasing incidence rate due to multi-drug resistant tuberculosis (MDRTb) is further escalating growth prospects across this region.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe
- Growing awareness about TB and its diagnosis and treatment options
- Rising demand for rapid, accurate, and affordable TB tests
- Proliferation of point-of-care TB testing devices and kits
- Growing number of public-private partnerships to combat tuberculosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Tuberculosis Testing Market Research Report
By Type
Smear Microscopy, Nucleic Acid Testing, Radiography, Culture Based Tests, Drug Susceptibility Testing, Others
By Application
Hospitals, Laboratories, Others
By Companies
Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific, bioMérieux SA, Siemens Healthineer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Tuberculosis Testing Market Report Segments:
The global Tuberculosis Testing market is segmented on the basis of:
Types
Smear Microscopy, Nucleic Acid Testing, Radiography, Culture Based Tests, Drug Susceptibility Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Akonni Biosystems
- Abbott
- Becton, Dickinson and Company
- Cepheid
- Epistem Holdings Plc
- F. Hoffmann-La Roche AG
- Thermo Fischer Scientific
- bioMérieux SA
- Siemens Healthineer
Highlights of The Tuberculosis Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Smear Microscopy
- Nucleic Acid Testing
- Radiography
- Culture Based Tests
- Drug Susceptibility Testing
- Others
- By Application:
- Hospitals
- Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tuberculosis Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tuberculosis testing is a medical procedure that is used to determine if someone has tuberculosis. This test can also help doctors diagnose other lung diseases, such as bronchitis, pneumonia, and emphysema.
Some of the major players in the tuberculosis testing market are Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific, bioM©rieux SA, Siemens Healthineer.
The tuberculosis testing market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tuberculosis Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tuberculosis Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tuberculosis Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tuberculosis Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tuberculosis Testing Market Size & Forecast, 2018-2028
4.5.1 Tuberculosis Testing Market Size and Y-o-Y Growth
4.5.2 Tuberculosis Testing Market Absolute $ Opportunity
Chapter 5 Global Tuberculosis Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tuberculosis Testing Market Size Forecast by Type
5.2.1 Smear Microscopy
5.2.2 Nucleic Acid Testing
5.2.3 Radiography
5.2.4 Culture Based Tests
5.2.5 Drug Susceptibility Testing
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tuberculosis Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tuberculosis Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Laboratories
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tuberculosis Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tuberculosis Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tuberculosis Testing Analysis and Forecast
9.1 Introduction
9.2 North America Tuberculosis Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tuberculosis Testing Market Size Forecast by Type
9.6.1 Smear Microscopy
9.6.2 Nucleic Acid Testing
9.6.3 Radiography
9.6.4 Culture Based Tests
9.6.5 Drug Susceptibility Testing
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tuberculosis Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Laboratories
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tuberculosis Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Tuberculosis Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tuberculosis Testing Market Size Forecast by Type
10.6.1 Smear Microscopy
10.6.2 Nucleic Acid Testing
10.6.3 Radiography
10.6.4 Culture Based Tests
10.6.5 Drug Susceptibility Testing
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tuberculosis Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Laboratories
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tuberculosis Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tuberculosis Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tuberculosis Testing Market Size Forecast by Type
11.6.1 Smear Microscopy
11.6.2 Nucleic Acid Testing
11.6.3 Radiography
11.6.4 Culture Based Tests
11.6.5 Drug Susceptibility Testing
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tuberculosis Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Laboratories
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tuberculosis Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Tuberculosis Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tuberculosis Testing Market Size Forecast by Type
12.6.1 Smear Microscopy
12.6.2 Nucleic Acid Testing
12.6.3 Radiography
12.6.4 Culture Based Tests
12.6.5 Drug Susceptibility Testing
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tuberculosis Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Laboratories
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tuberculosis Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tuberculosis Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tuberculosis Testing Market Size Forecast by Type
13.6.1 Smear Microscopy
13.6.2 Nucleic Acid Testing
13.6.3 Radiography
13.6.4 Culture Based Tests
13.6.5 Drug Susceptibility Testing
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tuberculosis Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Laboratories
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tuberculosis Testing Market: Competitive Dashboard
14.2 Global Tuberculosis Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Akonni Biosystems
14.3.3 Abbott
14.3.4 Becton, Dickinson and Company
14.3.5 Cepheid
14.3.6 Epistem Holdings Plc
14.3.7 F. Hoffmann-La Roche AG
14.3.8 Thermo Fischer Scientific
14.3.9 bioMérieux SA
14.3.10 Siemens Healthineer
